Uli Christian BROEDL,Sreeraj MACHA,Maximilian von EYNATTEN,Hans-Juergen WOERLE
申请号：
US16288192
公开号：
US20190350957A1
申请日:
2019.02.28
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention relates to certain SGLT-2 inhibitors for treating and/or preventing metabolic disorders, such as type 1 or type 2 diabetes mellitus or pre-diabetes, in patients with renal impairment or chronic kidney disease (CKD).
